Literature DB >> 12559377

Kinetic inhibitory profile of BIA 3-202, a novel fast tight-binding, reversible and competitive catechol-O-methyltransferase inhibitor.

Maria João Bonifácio1, Maria Augusta Vieira-Coelho, Patrício Soares-da-Silva.   

Abstract

The present study reports the kinetic inhibitory profile of 1-[3,4-dihydroxy-5-nitrophenyl]-2-phenyl-ethanone (BIA 3-202), a novel inhibitor of soluble catechol-O-methyltransferase (COMT) in rat liver. After an oral single dose (30 mg kg(-1)), there was a time-dependent recovery of enzyme activity from 98+/-2% inhibition at 30 min to total recovery at 24 h after treatment. The inhibitory effect produced by BIA 3-202 on soluble COMT was reversible after gel filtration of the samples. BIA 3-202 acted as a fast inhibitor of rat liver soluble COMT, interacting immediately with the enzyme after mixing. No differences were observed in the metanephrine formation rates (in nmol mg protein(-1) min(-1)) obtained without and with a 60-min preincubation with 30 nM of BIA 3-202 (1.30+/-0.02 and 1.35+/-0.03, respectively). The tight-binding nature of the inhibition produced by BIA 3-202 was evaluated by performing an Ackermann-Potter plot. The true K(i) for BIA 3-202, derived from the nonlinear regression analysis, was 0.19+/-0.02 nM. In substrate competition studies, an increase in the concentration of adrenaline resulted in a linear increase in IC(50) values for BIA 3-202. In conclusion, BIA 3-202 behaves as a reversible, potent and fast tight-binding COMT inhibitor that acts competitively at the substrate binding site of rat liver soluble COMT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559377     DOI: 10.1016/s0014-2999(02)02879-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat.

Authors:  M J Bonifácio; L Torrão; A I Loureiro; P N Palma; L C Wright; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

2.  Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide.

Authors:  Pedro Silveira; Manuel Vaz-da-Silva; Luis Almeida; Joana Maia; Amilcar Falcão; Ana Loureiro; Leonel Torrão; Rita Machado; Lyndon Wright; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

3.  Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping.

Authors:  Ana I Loureiro; Carlos Fernandes-Lopes; Maria João Bonifácio; Filipa Sousa; László E Kiss; Patricio Soares-da-Silva
Journal:  Pharmacol Res Perspect       Date:  2022-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.